Yield10 Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2002
Net Income	-13.15	-14.46	-13.57	-11.03	-10.21	-12.96	Upgrade
Depreciation & Amortization	0.29	0.29	0.26	0.22	0.18	0.2	Upgrade
Share-Based Compensation	1.54	1.59	1.9	1.68	0.74	0.66	Upgrade
Other Operating Activities	3.02	2.51	-0	-0.12	0.63	3.44	Upgrade
Operating Cash Flow	-8.3	-10.07	-11.4	-9.25	-8.66	-8.65	Upgrade
Capital Expenditures	-0.04	-0.05	-0.15	-0.19	-0.08	-0.06	Upgrade
Acquisitions	0	0	-8.68	4.39	0.01	2.95	Upgrade
Change in Investments	-	-1.99	-13.57	-16.89	-17.98	-8.45	Upgrade
Other Investing Activities	-	3.98	30.92	8.11	17.4	2.55	Upgrade
Investing Cash Flow	-0.04	1.95	8.52	-4.58	-0.65	-3.02	Upgrade
Common Stock Issued	-0.08	5.95	0	15.85	5.31	14.08	Upgrade
Share Repurchases	0.04	-0.04	-0.04	-0.1	-0.02	-0	Upgrade
Other Financing Activities	8.06	0.89	-0.07	-0.21	1.96	-0.01	Upgrade
Financing Cash Flow	7.94	6.87	-0.04	15.75	7.28	14.08	Upgrade
Net Cash Flow	-0.43	-1.29	-2.97	1.91	-2.06	2.39	Upgrade
Free Cash Flow	-8.34	-10.11	-11.56	-9.44	-8.74	-8.72	Upgrade
Free Cash Flow Margin	-2316.94%	-16856.67%	-2568.44%	-1537.79%	-1093.24%	-1081.27%	Upgrade
Free Cash Flow Per Share	-16.09	-30.55	-56.44	-47.89	-88.33	-573.09	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.